Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TMO | MRK |
|---|---|---|
| Price | $672.85 | $148.59 |
| Change today | ▲ 1.13% | ▲ 0.34% |
| Market cap | $248.78B | $366.60B |
| Return, 3 months | +36.7% | +23.2% |
| Return, year to date | +16.4% | +43.2% |
| Return, 1 year | +44.2% | +90.9% |
| P/E (TTM) | 36.2 | 118.9 |
| P/B | 4.7 | 8.7 |
| P/E percentile vs own 5y | 63rd | 89th |
| Dividend yield | 0.27% | 2.26% |
| Revenue growth (YoY, latest qtr) | +10.5% | +5.1% |
| Net profit growth (YoY) | +7.6% | -130.2% |
| Gross margin | 40.8% | 73.0% |
| Operating margin | 18.3% | 10.5% |
| Net margin | 15.0% | 4.8% |
| Return on equity | 13.5% | 7.0% |
| Analyst target vs. price | -4.9% | +9.8% |
| Analyst buy share | 83% | 83% |
| RSI (14) | 69 | 59 |
| 30-day volatility | 24.7% | 41.9% |
| Max drawdown, 1 year | -31.4% | -11.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.